Secondary systemic amyloidosis: response and survival in 64 patients - PubMed (original) (raw)
Affiliations
- PMID: 2067409
Secondary systemic amyloidosis: response and survival in 64 patients
M A Gertz et al. Medicine (Baltimore). 1991 Jul.
Abstract
From 1956 through 1989, 38 men and 26 women were seen at the Mayo Clinic with biopsy-proven AA. The underlying disorder was rheumatic disease in 42, infectious disease in 11, inflammatory bowel disease in 6, and other causes in 5. All patients were symptomatic at the time of diagnosis. Fifty-eight of the 64 patients had proteinuria or renal insufficiency. Fourteen also had significant symptoms of gastrointestinal amyloid, and 6 had amyloid goiter. None of the patients had symptomatic cardiac involvement, and only 3 had palpable hepatomegaly. Renal, gastric, rectal, fat, and marrow biopsies were positive for amyloid in 100%, 94%, 82%, 58%, and 46% of tested patients, respectively. The median survival of the entire group was 24.5 months. Thirty-five of the 47 deceased patients died as a direct result of their amyloidosis, primarily from complications of renal failure. Nine were successfully treated and had regression of the disease. Two with bronchiectasis responded to long-term cyclic antibiotic therapy, as did 1 patient with osteomyelitis. One patient with inflammatory bowel disease responded to surgical resection, and 1 with familial Mediterranean fever responded to colchicine. Four patients with rheumatic disease were treated with cyclophosphamide (in 2) and methotrexate (in 2), with complete resolution of their renal disease. All 9 successfully treated patients are alive, with a median follow-up of 58 months. Statistical analysis revealed that creatinine values greater than or equal to 2.0 mg/dl (P less than 0.003) and a serum albumin value less than 2.5 g/dl (P less than 0.02) were associated with a poorer survival. The single strongest variable associated with poor survival was a serum creatinine level greater than 2 mg/dl at presentation, with a median survival of 11.2 months compared to patients with a creatinine level less than 2.0 mg/dl, with a median survival of 56.9 months.
Similar articles
- Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M; Immunopathology Group of the Italian Society of Nephrology. Bergesio F, et al. Nephrol Dial Transplant. 2008 Mar;23(3):941-51. doi: 10.1093/ndt/gfm684. Epub 2007 Oct 19. Nephrol Dial Transplant. 2008. PMID: 17951308 - Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
Gertz MA, Kyle RA, O'Fallon WM. Gertz MA, et al. Arch Intern Med. 1992 Nov;152(11):2245-50. Arch Intern Med. 1992. PMID: 1444684 - Renal amyloidosis followed more than 5 years: report of 12 cases.
Kaaroud H, Boubaker K, Béji S, Abderrahim E, Moussa FB, Turki S, Goucha R, Hedri H, El Younsi F, Kheder A, Maiz HB. Kaaroud H, et al. Transplant Proc. 2004 Jul-Aug;36(6):1796-8. doi: 10.1016/j.transproceed.2004.07.022. Transplant Proc. 2004. PMID: 15350480 - Amyloidosis (AL). Clinical and laboratory features in 229 cases.
Kyle RA, Greipp PR. Kyle RA, et al. Mayo Clin Proc. 1983 Oct;58(10):665-83. Mayo Clin Proc. 1983. PMID: 6353084 Review. - [Systemic amyloidosis in inflammatory bowel disease].
Naves JE, Domènech E. Naves JE, et al. Gastroenterol Hepatol. 2012 Apr;35(4):259-65. doi: 10.1016/j.gastrohep.2011.11.001. Epub 2011 Dec 15. Gastroenterol Hepatol. 2012. PMID: 22177266 Review. Spanish.
Cited by
- AA Amyloidosis: A Contemporary View.
Mirioglu S, Uludag O, Hurdogan O, Kumru G, Berke I, Doumas SA, Frangou E, Gul A. Mirioglu S, et al. Curr Rheumatol Rep. 2024 Jul;26(7):248-259. doi: 10.1007/s11926-024-01147-8. Epub 2024 Apr 3. Curr Rheumatol Rep. 2024. PMID: 38568326 Free PMC article. Review. - Two Cases of Gastric and Esophageal Amyloidosis: Review.
Ebert EC. Ebert EC. Gastroenterol Hepatol (N Y). 2009 Aug;5(8):575-576. Gastroenterol Hepatol (N Y). 2009. PMID: 37967411 Free PMC article. Review. No abstract available. - Kidney Biopsy Findings and Clinical Outcomes of US Veterans with Inflammatory Bowel Disease.
Ravipati P, Reule S, Bren A, Bu L, Vaughn BP, Nachman PH. Ravipati P, et al. Glomerular Dis. 2023 Sep 30;3(1):233-240. doi: 10.1159/000534062. eCollection 2023 Jan-Dec. Glomerular Dis. 2023. PMID: 37915861 Free PMC article. - Risk of Chronic Kidney Disease in Hospitalized Patients with Hidradenitis Suppurativa.
Almuhanna N, Tobe SW, Alhusayen R. Almuhanna N, et al. Dermatology. 2023;239(6):912-918. doi: 10.1159/000531960. Epub 2023 Jul 24. Dermatology. 2023. PMID: 37487485 Free PMC article. - Rheumatoid Arthritis With Focal Segmental Glomerulosclerosis: A Case Report and Literature Review.
Albandak M, Ayyad M, Abu Ajamia S, Quntar A, Al-Karaja L, Alsaid HM, Alamlih L. Albandak M, et al. Cureus. 2023 Apr 5;15(4):e37161. doi: 10.7759/cureus.37161. eCollection 2023 Apr. Cureus. 2023. PMID: 37153240 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical